These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21220252)

  • 41. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
    Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
    Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. β-blockers in COPD - yes, it's OK (with care).
    Bryant L
    J Prim Health Care; 2012 Jun; 4(2):165. PubMed ID: 22852168
    [No Abstract]   [Full Text] [Related]  

  • 45. Beta-blockers for treatment of hypertension.
    Basile JN; Cohen JD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):11-7. PubMed ID: 19667665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary effects of nebivolol.
    Dal Negro R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians.
    Qaseem A; Snow V; Shekelle P; Sherif K; Wilt TJ; Weinberger S; Owens DK;
    Ann Intern Med; 2007 Nov; 147(9):633-8. PubMed ID: 17975186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
    Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
    Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of COPD: moving beyond the lungs.
    Matera MG; Calzetta L; Rinaldi B; Cazzola M
    Curr Opin Pharmacol; 2012 Jun; 12(3):315-22. PubMed ID: 22552103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Other important applications for beta-blockers in high-risk patients.
    Egan BM; Chilton RJ
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):35-48. PubMed ID: 19667668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
    Rasmussen DB; Lange P; Jensen MT
    Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of beta-blockers in chronic congestive heart failure.
    Mahanonda N; Samranthin M; Panyarachun S
    J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. β-Blockers, heart disease and COPD: current controversies and uncertainties.
    Baker JG; Wilcox RG
    Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-blockers in COPD: time for reappraisal.
    Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
    Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
    Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
    Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
    Leitao Filho FS; Choi L; Sin DD
    Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.
    Wade C; Wells JM
    Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.